Anterix Inc.
ATEX · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.44 | 1.55 | 0.66 | 0.83 |
| FCF Yield | -6.98% | 3.99% | -8.74% | -0.90% |
| EV / EBITDA | -13.15 | -10.91 | -10.93 | -20.44 |
| Quality | ||||
| ROIC | -4.54% | -3.94% | -7.13% | -13.94% |
| Gross Margin | 100.00% | 100.00% | 99.74% | 99.54% |
| Cash Conversion Ratio | 2.57 | -4.60 | 1.67 | -0.48 |
| Growth | ||||
| Revenue 3-Year CAGR | 46.48% | 56.95% | 27.72% | -11.50% |
| Free Cash Flow Growth | -292.44% | 145.34% | -472.54% | 60.64% |
| Safety | ||||
| Net Debt / EBITDA | 0.87 | 1.07 | 0.72 | 2.15 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | -0.02 |
| Cash Conversion Cycle | 607.20 | 442.53 | -55,035.50 | -93,505.86 |